What is Aida Rechdouni's NPI number?

Aida Rechdouni's National Provider Identifier (NPI) is 1699814533, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Aida Rechdouni's specialty?

Aida Rechdouni is listed in the NPPES registry with a primary specialty of Anatomic Pathology Physician (Allopathic & Osteopathic Physicians).

Where is Aida Rechdouni located?

Aida Rechdouni's practice location on file with NPPES is 2626 Foothill Blvd Ste 102, La Crescenta, CA 91214-3574.

What is Aida Rechdouni's phone number?

The practice phone number listed in the NPPES registry for Aida Rechdouni is (888) 610-8909.

Does Aida Rechdouni accept Medicare?

Aida Rechdouni is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Aida Rechdouni's NPI active?

Yes — Aida Rechdouni's NPI (1699814533) is active in the NPPES registry as of the last update on 2026-02-24.

IndividualActiveAccepts Medicare

Aida Rechdouni, M.D.

NPI 1699814533 · Anatomic Pathology Physician · La Crescenta, CA

Aida Rechdouni, M.D. is a Anatomic Pathology Physician provider in La Crescenta, CA (NPI 1699814533).

Provider details

NPI number: 1699814533
Entity type: Individual
Primary specialty: Anatomic Pathology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: Yes
License: A72786 (CA)

Practice location

2626 Foothill Blvd Ste 102

La Crescenta, CA 91214-3574

Phone: (888) 610-8909

Fax: (888) 610-8908

Street-level locationGet directions

More CA providers

Mailing address

2750 Pineridge Pl

La Crescenta, CA 91214-1458

Specialties & taxonomies

Anatomic Pathology PhysicianPrimary207ZP0101XLicense A72786 (CA)
Allopathic & Osteopathic Physicians
Clinical Medical Laboratory291U00000XLicense A72786 (CA)
Laboratories

Enrolled with Medicare as Practitioner - Pathology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(94/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
7,722 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	4,204	$66
Special Stained Specimen Slides to Examine Tissue Including Interpretation and Report88313	2,021	$76
Special Stained Specimen Slides to Identify Organisms Including Interpretation and Report88312	1,366	$103
Special Stained Specimen Slides to Examine Tissue, Initial Procedure88342	91	$109
Cell Examination of Specimen, Selective Cellular Enhancement Technique88112	40	$77

Typical Medicare-allowed amounts for these services range $66–$109 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.

Drug	Part D claims (2024)
Cyclosporine	18
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	18
Azelastine Hcl	12
Empagliflozin/Metformin Hclbrand: Synjardy	12
Levothyroxine Sodium	11
Memantine Hclbrand: Memantine Hcl Er	11
Pantoprazole Sodium	11
Trazodone Hcl	11

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$18 across 1 record (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-02-06
Last updated: 2026-02-24
Certified: 2026-02-24

Frequently asked questions

What is Aida Rechdouni's NPI number?: Aida Rechdouni's National Provider Identifier (NPI) is 1699814533, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Aida Rechdouni's specialty?: Aida Rechdouni is listed in the NPPES registry with a primary specialty of Anatomic Pathology Physician (Allopathic & Osteopathic Physicians).
Where is Aida Rechdouni located?: Aida Rechdouni's practice location on file with NPPES is 2626 Foothill Blvd Ste 102, La Crescenta, CA 91214-3574.
What is Aida Rechdouni's phone number?: The practice phone number listed in the NPPES registry for Aida Rechdouni is (888) 610-8909.
Does Aida Rechdouni accept Medicare?: Aida Rechdouni is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Aida Rechdouni's NPI active?: Yes — Aida Rechdouni's NPI (1699814533) is active in the NPPES registry as of the last update on 2026-02-24.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	4,204	$66
Special Stained Specimen Slides to Examine Tissue Including Interpretation and Report88313	2,021	$76
Special Stained Specimen Slides to Identify Organisms Including Interpretation and Report88312	1,366	$103
Special Stained Specimen Slides to Examine Tissue, Initial Procedure88342	91	$109
Cell Examination of Specimen, Selective Cellular Enhancement Technique88112	40	$77

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.

Drug	Part D claims (2024)
Cyclosporine	18
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	18
Azelastine Hcl	12
Empagliflozin/Metformin Hclbrand: Synjardy	12
Levothyroxine Sodium	11
Memantine Hclbrand: Memantine Hcl Er	11
Pantoprazole Sodium	11
Trazodone Hcl	11

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$18 across 1 record (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments